Yingwen Wu studied Chemistry (B.Sc.) at the Christian Albrechts University in Kiel. After finishing her bachelor thesis on the synthesis of a “reversible photoswitchable CK1δ-inhibitor”, she started her master in Medicinal and Natural Product Chemistry (M.Sc.) at the Gottfried Wilhelm Leibniz University in Hanover. She finished her studies in 2019 with her master thesis on the “Rational engineering of fungal highly-reducing polyketide synthase”. She joined the Empting’s group in the same year as a PhD student. Her research focuses on the biophysical screening of novel starting points for anti-infectives and antivirus agents with CsrA/RsmA as the bacterial target and targets in the herpes viral life cycle.